Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$60,814
11 notices · 56,886 sh
Oct 2025 to Oct 2026
Reported ·
$75,708
15 sales · 3 buys · $97,011 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 15 reported sales carry the 10b5-1 box. Together they are 0.03% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-14Russotti Gregory, See Remarks$4,994
2,587 shno plan dateForm 4s on file end Jun 23144 ↗ 2026-09-14Carr Douglas, SVP Finance & Operations$3,201
1,658 shno plan dateForm 4s on file end Jun 23144 ↗ 2026-09-08Russotti Gregory, See Remarks$1,094
534 shno plan dateForm 4s on file end Jun 23144 ↗ 2026-06-12Russotti Gregory, See Remarks$5,768
2,584 shno plan date144 ↗ Form 4, 2026-06-15: sold 2,584 at $2.23
Form 4 ↗2026-06-08Russotti Gregory, See Remarks$1,106
Form 4, 2026-06-09: sold 524 at $2.11
Form 4 ↗2026-03-12Russotti Gregory, See Remarks$25,686
10,076 shno plan date144 ↗ Form 4, 2026-03-16: sold 10,076 at $2.55
Form 4 ↗2026-03-09Russotti Gregory, See Remarks$1,215
Form 4, 2026-03-11: sold 479 at $2.54
Form 4 ↗2025-12-08Pfeiffenberger Brent, President and CEO$0
0 shno plan dateno Form 4 on file144 ↗ 2025-12-08Russotti Gregory, See Remarks$280
Form 4, 2025-12-10: sold 526 at $0.53
Form 4 ↗2025-11-20Cowan Chad, Chief Scientific Officer$2,739
5,462 shno plan date144 ↗ Form 4, 2025-11-24: sold 5,462 at $0.50
Form 4 ↗2025-11-17Pfeiffenberger Brent, President and CEO$14,732
32,456 shno plan date144 ↗ Form 4, 2025-11-19: sold 32,456 at $0.45
Form 4 ↗